These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 2017528)

  • 1. Relationship between the Brief Psychiatric Rating Scale and the Scale for the Assessment of Negative Symptoms: a study of their correlation and redundancy.
    Czobor P; Bitter I; Volavka J
    Psychiatry Res; 1991 Feb; 36(2):129-39. PubMed ID: 2017528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choosing negative symptom instruments: issues of representation and redundancy.
    Welham J; Stedman T; Clair A
    Psychiatry Res; 1999 Jul; 87(1):47-56. PubMed ID: 10512154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a linear relationship between the Brief Psychiatric Rating Scale and the Clinical Global Impression-Schizophrenia scale? A retrospective analysis.
    Sawamura J; Morishita S; Ishigooka J
    BMC Psychiatry; 2010 Dec; 10():105. PubMed ID: 21134296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability, and predictive validity.
    Bell M; Milstein R; Beam-Goulet J; Lysaker P; Cicchetti D
    J Nerv Ment Dis; 1992 Nov; 180(11):723-8. PubMed ID: 1431824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability in BPRS definitions of positive and negative symptoms.
    Nicholson IR; Chapman JE; Neufeld RW
    Schizophr Res; 1995 Oct; 17(2):177-85. PubMed ID: 8562492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dimensional structure of the German version of the Brief Psychiatric Rating Scale (BPRS)].
    Mass R; Burmeister J; Krausz M
    Nervenarzt; 1997 Mar; 68(3):239-44. PubMed ID: 9198784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
    McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
    Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hopelessness in schizophrenia: the impact of symptoms and beliefs about illness.
    White RG; McCleery M; Gumley AI; Mulholland C
    J Nerv Ment Dis; 2007 Dec; 195(12):968-75. PubMed ID: 18091189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The brief psychiatric rating scale: effect of scaling system on clinical response assessment.
    Thompson PA; Buckley PF; Meltzer HY
    J Clin Psychopharmacol; 1994 Oct; 14(5):344-6. PubMed ID: 7806691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stability of positive and negative symptom constructs during neuroleptic treatment in schizophrenia.
    Goldman RS; Tandon R; Liberzon I; Goodson J; Greden JF
    Psychopathology; 1991; 24(4):247-52. PubMed ID: 1754657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychometric evaluation of a standardized and expanded Brief Psychiatric Rating Scale.
    Hafkenscheid A
    Acta Psychiatr Scand; 1991 Sep; 84(3):294-300. PubMed ID: 1950632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of instrument sensitivity to negative symptom change.
    Eckert SL; Diamond PM; Miller AL; Velligan DI; Funderburg LG; True JE
    Psychiatry Res; 1996 Jun; 63(1):67-75. PubMed ID: 8832775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychometric analysis in support of shortening the Scale for the Assessment of Negative Symptoms.
    Levine SZ; Leucht S
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):1051-6. PubMed ID: 23228891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does catatonia influence the phenomenology of childhood onset schizophrenia beyond motor symptoms?
    Bonnot O; Tanguy ML; Consoli A; Cornic F; Graindorge C; Laurent C; Tordjman S; Cohen D
    Psychiatry Res; 2008 Apr; 158(3):356-62. PubMed ID: 18272234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Symptom assessment in early psychosis: the use of well-established rating scales in clinical high-risk and recent-onset populations.
    Fulford D; Pearson R; Stuart BK; Fisher M; Mathalon DH; Vinogradov S; Loewy RL
    Psychiatry Res; 2014 Dec; 220(3):1077-83. PubMed ID: 25278477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The sensitivity of quality-of-life scale WHOQOL-100 to psychopathological measures in schizophrenia.
    Orsel S; Akdemir A; Dağ I
    Compr Psychiatry; 2004; 45(1):57-61. PubMed ID: 14671738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinguishing depression and negative symptoms in unmedicated patients with schizophrenia.
    Newcomer JW; Faustman WO; Yeh W; Csernansky JG
    Psychiatry Res; 1990 Mar; 31(3):243-50. PubMed ID: 2333356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relations among clinical scales in schizophrenia.
    Gur RE; Mozley PD; Resnick SM; Levick S; Erwin R; Saykin AJ; Gur RC
    Am J Psychiatry; 1991 Apr; 148(4):472-8. PubMed ID: 2006693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical predictors of discrepancy between self-ratings and examiner ratings for negative symptoms.
    Selten JP; Wiersma D; van den Bosch RJ
    Compr Psychiatry; 2000; 41(3):191-6. PubMed ID: 10834628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.